What is Unipharma?
Unipharma operates as a critical link in the healthcare supply chain, providing comprehensive pharmacy solutions tailored for Skilled Nursing Facilities (SNF), Intermediate Care Facilities (ICF), and Board & Care environments. The company distinguishes itself through a robust suite of services, including advanced dispensing systems, oral supplement management, and integrated medication administration records. By offering 24-hour emergency pharmacist access and same-day delivery, Unipharma addresses the acute logistical challenges faced by institutional care providers. Their business model focuses on seamless integration with existing facility workflows, effectively reducing administrative burden while improving patient safety through automated drug interaction reporting and detailed patient profiling.
How much funding has Unipharma raised?
Unipharma has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Unipharma
PPP
Public-Private Partnership
What's next for Unipharma?
With this late-stage funding secured, Unipharma is expected to prioritize the expansion of its technological infrastructure and service reach. The strategic roadmap likely involves scaling its proprietary dispensing systems to accommodate a broader client base while maintaining the high-touch, 24-hour service standards that define its market position. As the long-term care industry faces increasing pressure to digitize and optimize medication management, Unipharma is well-positioned to capture additional market share. Future growth will likely be driven by further investment in staff training programs and the refinement of its digital health interfaces, ensuring that the company remains a preferred partner for healthcare facilities seeking to improve clinical outcomes and operational efficiency.
See full Unipharma company page
